Guardant Health (GH) Stock Rockets on Earnings Beat and New Cancer-Screening Wins
Strong Q3 Earnings Propel Stock Higher Guardant’s latest quarterly report blew past Wall Street’s expectations, sparking a sharp rally in its shares. For Q3 2025, revenue was $265.2 million, a 39% jump